Rule 3.1 - Once an entity is or becomes aware of any information concerning it that a reasonable person would expect to have a material effect on the price or value of the entity’s securities, the entity must immediately tell ASX that information.
When AnteoTech informed the market that they were seeking the CE Mark for their test so that it could be sold in Europe, it seemed to give the impression that the test could be sold on the grant of the CE Mark. Was the company aware that this was not the case and that each jurisdiction required individual approval as well as the CE Mark?
Would this have changed the sentiment of some shareholders and therefore likely to have a material effect on the price of the shares?
Yes, I would think so.
Did a member of the board raise this very point and find their protests over ruled by the majority?
I have no interest in changing my strategy but I feel sure quite a few would have, had they been given all the information. If, this has actually been the case.
- Forums
- ASX - By Stock
- ADO
- Three rat tests approved
Three rat tests approved, page-49
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.83M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.414K | 161.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 616353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 384663 | 0.021 |
12 | 2157550 | 0.020 |
10 | 3040767 | 0.019 |
10 | 1652665 | 0.018 |
3 | 94160 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 616353 | 6 |
0.023 | 857853 | 5 |
0.024 | 1306228 | 3 |
0.025 | 214144 | 4 |
0.027 | 680612 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |